Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection

被引:31
|
作者
Fu, Wei [1 ]
Song, Zhiqiang [1 ]
Zhou, Liya [1 ]
Xue, Yan [1 ]
Ding, Yu [1 ]
Suo, Baojun [1 ]
Tian, Xueli [1 ]
Wang, Li [1 ]
机构
[1] Peking Univ, Hosp 3, Dept Gastroenterol, 49 North Garden Rd, Beijing 100191, Peoples R China
关键词
Helicobacter pylori; Eradication; Amoxicillin; Cefuroxime; Safety; Compliance; PENICILLIN-ALLERGIC PATIENTS; TRIPLE PLUS BISMUTH; ANTIBIOTIC-RESISTANCE; THERAPY; MANAGEMENT; CEPHALOSPORINS; CLARITHROMYCIN; METRONIDAZOLE; MULTICENTER; EFFICACY;
D O I
10.1007/s10620-017-4564-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The eradication of Helicobacter pylori infection remains a challenge, especially in the patients unsuitable to take penicillin. Cephalosporin has the potential to replace amoxicillin for H. pylori eradication. To compare the effectiveness, safety, and compliance of amoxicillin- and cefuroxime-containing quadruple regimens in treatment-na < ve patients. In this open-label randomized control study, 400 patients with H. pylori infection were divided into amoxicillin-containing (esomeprazole 20 mg twice/day, amoxicillin 1000 mg twice/day, levofloxacin 500 mg once/day, and bismuth 220 mg twice/day for 14 days) or cefuroxime-containing (esomeprazole 20 mg twice/day, cefuroxime 500 mg twice/day, levofloxacin 500 mg once/day, and bismuth 220 mg twice/day for 14 days) quadruple therapy groups. The safety and compliance were assessed 1-3 days after eradication. Urea breath test was performed 8-12 weeks after eradication to determine treatment outcome. The baseline data including antibiotic resistance were well matched between the two groups. The eradication rates between amoxicillin- and cefuroxime-containing quadruple therapy groups were not significantly different [intention-to-treat analysis: 83.5% (95% confidence interval 78.3-88.7%) vs. 81.0% (75.5-86.5%), P = 0.513; modified intention-to-treat analysis: 90.3% (86.0-94.6%) vs. 88.5% (83.9-93.2%), P = 0.586; per-protocol analysis: 91.6% (87.5-95.7%) vs. 89.8% (85.3-94.3%), P = 0.560]. The incidence of adverse effects (18.4 vs. 20.1%, P = 0.678) and compliance (94.7 vs. 94.2%, P = 0.813) were also similar. Variate analyses showed that antibiotic resistance and poor compliance were the independent risk factors for eradication failure. Esomeprazole, bismuth, levofloxacin, and amoxicillin or cefuroxime achieved similar and relatively satisfactory cure rates, safety, and compliance in first-line H. pylori eradication. Cefuroxime may be a good alternative medicine for eradication instead of amoxicillin for the patients unsuitable to take penicillin.
引用
收藏
页码:1580 / 1589
页数:10
相关论文
共 50 条
  • [1] Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection
    Wei Fu
    Zhiqiang Song
    Liya Zhou
    Yan Xue
    Yu Ding
    Baojun Suo
    Xueli Tian
    Li Wang
    Digestive Diseases and Sciences, 2017, 62 : 1580 - 1589
  • [2] Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
    Song, Zhiqiang
    Fu, Wei
    Zhou, Liya
    BMC GASTROENTEROLOGY, 2019, 19 (1)
  • [3] Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial
    Suo, Baojun
    Tian, Xueli
    Zhang, Hua
    Lu, Haoping
    Li, Cailing
    Zhang, Yuxin
    Ren, Xinlu
    Yao, Xingyu
    Zhou, Liya
    Song, Zhiqiang
    CHINESE MEDICAL JOURNAL, 2023, 136 (08) : 933 - 940
  • [4] Esomeprazole, minocycline, metronidazole and bismuth as first-line and second-line regimens for Helicobacter pylori eradication
    Song, Zhi Qiang
    Zhou, Li Ya
    JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (04) : 260 - 267
  • [5] Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
    Zhiqiang Song
    Wei Fu
    Liya Zhou
    BMC Gastroenterology, 19
  • [6] Rabeprazole, Minocycline, Amoxicillin, and Bismuth as First-Line and Second-Line Regimens for Helicobacter pylori Eradication
    Song, Zhiqiang
    Suo, Baojun
    Zhang, Lingyun
    Zhou, Liya
    HELICOBACTER, 2016, 21 (06) : 462 - 470
  • [7] Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial
    Tian, Xue-li
    Suo, Bao-jun
    Zhang, Hua
    Lu, Hao-ping
    Li, Cai-ling
    Zhang, Yu-xin
    Ren, Xin-lu
    Yao, Xing-yu
    Zhou, Li-ya
    Song, Zhi-qiang
    HELICOBACTER, 2023, 28 (01)
  • [8] New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial
    Zhang, Yuxin
    Suo, Baojun
    Tian, Xueli
    Zhang, Hua
    Lu, Haoping
    Yao, Xingyu
    Li, Cailing
    Ren, Xinlu
    Zhou, Liya
    Song, Zhiqiang
    HELICOBACTER, 2023, 28 (02)
  • [9] Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication
    Molina-Infante, J.
    Perez-Gallardo, B.
    Fernandez-Bermejo, M.
    Hernandez-Alonso, M.
    Vinagre, G.
    Duenas, C.
    Mateos-Rodriguez, J. M.
    Gonzalez-Garcia, G.
    Abadia, E. G.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (10) : 1077 - 1084
  • [10] Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
    Bang, Chang Seok
    Lim, Hyun
    Jeong, Hae Min
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    GUT MICROBES, 2020, 11 (05) : 1314 - 1323